IOVA
Iovance Biotherapeutics Inc
NASDAQ · Biotechnology
$2.53
+0.17 (+7.20%)
Open$2.42
Previous Close$2.36
Day High$2.58
Day Low$2.42
52W High$6.16
52W Low$1.64
Volume—
Avg Volume12.08M
Market Cap1.00B
P/E Ratio—
EPS$-1.20
SectorBiotechnology
Analyst Ratings
Buy
18 analysts
Price Target
+2,064.8% upside
Current
$2.53
$2.53
Target
$54.77
$54.77
$41.45
$54.77 avg
$77.23
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 224.68M | 337.04M | 333.93M |
| Net Income | -509,667,123 | 23.64M | 18.09M |
| Profit Margin | -226.8% | 7.0% | 5.4% |
| EBITDA | -524,910,692 | 42.24M | 40.52M |
| Free Cash Flow | — | 21.56M | 19.96M |
| Rev Growth | — | +17.4% | +6.9% |
| Debt/Equity | 0.00 | 0.20 | 0.17 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $223.43 | +2.01% | 165.4 | 394.89B |
| AMGN | Amgen Inc | $384.32 | +4.49% | 26.8 | 206.95B |
| GILD | Gilead Sciences Inc | $152.50 | +2.10% | 23.3 | 189.20B |
| VRTX | Vertex Pharmaceuticals Inc | $477.92 | +4.17% | 33.7 | 123.82B |
| REGN | Regeneron Pharmaceuticals | $785.51 | +2.46% | 18.4 | 83.03B |
| ALNY | Alnylam Pharmaceuticals Inc | $328.16 | -0.93% | 995.2 | 43.35B |